NSCLC patients with homozygous truncating SMARCA4 mutations had significantly worse OS on CIT compared to WT patients (HR 1.62, P = 0.01) (Fig. 2d). The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.